ORLANDO, May 5, 2020 /CNW/ – Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, is set to open the doors of a new Florida dispensary on Tuesday, May 5th. The new Central Florida location marks a record 47 locations in the state of Florida and 49 nationwide for Trulieve.
Located on Conroy Road, the dispensary joins Trulieve’s 46 other dispensaries statewide, and marks the fourth Trulieve storefront in the area, joining Orlando North, Orlando South, and Orlando Colonial.
“During the uncertainty brought on by COVID-19 over the past couple months, we have remained committed to our patients and our mission: to expand and ensure safe, reliable patient access statewide. We’ve taken proactive steps throughout the organization to keep our employees and our patients safe and will continue to exercise proactive safety precautions as the state reopens,” said Trulieve CEO Kim Rivers. “We are fortunate to broaden our brand in such a supportive community and we’re excited to open our Orlando Millennia store today. This will be one of our largest dispensaries, allowing us to continue to bring direct access to patients in the Orlando market, with online ordering, in-store pick-up options, and direct home delivery available to help patients statewide.”
Rivers added, “We will continue to update and adapt our policies and procedures companywide as new COVID-19 information comes out to protect the health and wellbeing of patients and employees.”
To commemorate the milestone location, all patients — from those new to Trulieve to our strong Truliever community — will be eligible for a 25% in-store discount at the Orlando Millennia location on the day of the opening.
For our new dispensary opening, Trulieve will continue to make our entire catalog of products available for ordering online, with in-store pickup, curbside pickup, or home delivery options available. Additionally, to assist with CDC guidelines for social distancing and company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients, including limiting visitors to the dispensary to patients only and modifying store layouts to assist with social distancing. A full list of initiatives enacted by Trulieve in response to COVID-19 are available online at Trulieve.com.
WHAT: Trulieve Orlando Opening
WHERE: 4192 Conroy Road, Suite 111, Orlando, Florida 32839
WHEN: Tuesday, May 5, 2020, at 9:00 AM
In stores and online, patients will find Florida’s largest selection of THC and CBD products, available in a variety of delivery methods, including smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients, and convenient in-store pick-up at its 47 dispensaries in locations across the state from Pensacola to Key West.
As the state’s leading medical cannabis provider, Trulieve’s employees are experienced, knowledgeable, and eager to help patients. Trulieve encourages potential patients, as well as patients who are new to cannabis and our wide array of products, to connect with the staff to learn more.
The Office of Medical Marijuana Use recently announced the registry was approaching 340,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume, per the Florida Department of Health. There are more than 2,500 registered ordering physicians in the State of Florida as well.
For more information, please visit www.Trulieve.com.
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.
SOURCE Trulieve Cannabis Corp.
For further information: Lynn Ricci, Director of Investor Relations — (850) 480-7955, IR@trulieve.com; Rachel Rivera, Public Relations — (850) 681-8530, email@example.com